Immediate Impact
57 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Targeting ROS in cancer: rationale and strategies
2024 Standout
Works of Boshi Sun being referenced
MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR/PI3K/AKT pathways
2019
Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Boshi Sun | 330 | 133 | 144 | 24 | 627 | |
| Ki Cheong Park | 353 | 185 | 111 | 35 | 647 | |
| Dongwei Jia | 332 | 121 | 128 | 22 | 565 | |
| Xundi Xu | 409 | 127 | 202 | 30 | 696 | |
| Tomoki Yagai | 329 | 81 | 102 | 19 | 704 | |
| Xingkai Liu | 353 | 115 | 91 | 39 | 659 | |
| Yoshiki Amuro | 337 | 218 | 87 | 52 | 727 | |
| Xijun Liu | 332 | 130 | 80 | 26 | 609 | |
| Kazuo Tsukidate | 243 | 112 | 101 | 32 | 679 | |
| Yoshiyuki Nishikawa | 469 | 129 | 111 | 28 | 739 | |
| Wenhao Qin | 298 | 109 | 262 | 29 | 712 |
All Works
Login with ORCID to disown or claim papers
Loading papers...